Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07278583

Evaluation of Heart Failure Telemonitoring Eligibility Criteria

Eligibility Criteria Evaluation of Heart Failure Telemonitoring : Analysis of CARDIAUVERGNE's Cohort

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
130 (estimated)
Sponsor
University Hospital, Clermont-Ferrand · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to analyze the prognosis and evolution of patients after exclusion of CARDIAUVERGNE, a heart failure telemonitoring system at Clermont-Ferrand's hospital. The patients were included from 1st January 2023 to 31st December 2024 and the monitoring was terminated for end of eligibility according to the french health authority criteria.

Detailed description

After an episode of heart failure, patients have been included in a telemonitoring program in order to reduce rehospitalizations for heart failure and improve follow-up. On a daily basis, the patients weigh themselves on connected scales which enables a team of dedicated nurses to follow them closely. If need be they can call the patient, ask for a blood exam and adapt their prescription. Indeed, if remote support is insufficient, patients can be hospitalized prematurely and so decrease the duration of hospital care. The inclusion criteria correspond to either an episode of heart failure in the last 12 months or dyspnea at least NYHA2 with NT-proBNP over 1000pg/mL. The follow up is renewed every 6 months. Patients are excluded from monitoring when criteria are no longer fulfilled. As these characteristics have been chosen empirically, our aim is to see if patients no longer presenting these standards have indeed a low chance of bad evolution. Information is gathered from their medical record at inclusion, exclusion and 1 year after exclusion. A short phone call is made after 1 year of exclusion, to appreciate their evolution and gather information concerning their symptoms, treatments ...

Conditions

Timeline

Start date
2025-12-01
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2025-12-12
Last updated
2025-12-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07278583. Inclusion in this directory is not an endorsement.